The correlation between the key pathogenic factor IL-17A and abnormal LCFA metabolism in psoriasis patients was further supported using IMQ-treated wild-type (WT) and T-cell receptor delta chain knockout (Tcrd−/−) mice. Here, IL17A is linked to psoriasis.